Why Is AVEANNA HEALTHCARE H (AVAH) Stock Up Today?
By the Top Tier Newswire AI Desk · August 13, 2026 at 3:30 PM ET · reviewed against 9 wire stories
AVEANNA HEALTHCARE H (AVAH) is up +26.35% in the latest session. Our newswire has captured 9 stories on AVAH across 7 sources in the last 36 hours, with AI sentiment reading bullish (avg 62/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Aveanna Healthcare Holdings Inc. (AVAH) shares surged 26.35% to $11.44 in a single session driven by the company’s second-quarter financial results and an upward revision of its 2026 guidance. The stock hit a five-year high as the company reported revenue of $670.48 million, a 13.7% increase year-over-year, and a non-GAAP EPS of $0.22, which beat estimates by $0.05. The firm also raised its full-year revenue forecast to more than $2.68 billion.
What Happened
The stock’s sharp rise followed the release of the company’s Q2 2026 earnings report, which showed double-digit revenue growth and improved profitability. Aveanna Healthcare’s second-quarter net income reached $40.3 million, up from $27 million in the same period the previous year. The company attributed the strong performance to segment growth and robust cash flow. An 8-K filing on August 13 confirmed the updated guidance and provided detailed financial statements. Truist Securities also adjusted its price target for the stock to $11, maintaining a Hold rating.
What The Data Shows
The intraday session reflected strong investor interest, with AVAH opening at $9.09 and climbing to a high of $11.48 at 3:15 PM ET. The stock closed near its peak at $11.45, with a volume of 6.5 million shares, significantly higher than the 3-month average. The stock’s market cap is now $2.0 billion, with a P/E ratio of 7.2. Recent insider transactions show 10 sales totaling $215.6 million in the last 90 days, with no insider purchases recorded.
What To Watch
The company has not scheduled an earnings date beyond the Q2 report. Investors should monitor the breadth of coverage and any follow-up analyst commentary on the revised 2026 guidance.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance
Second Quarter Revenue was $670.5 million, a 13.7% increase over the prior year period Second Quarter Net income was $40.3 million compared to $27.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →